|Type||Targeted Mutation Congenic|
|Former Common name||Eluc-Hes5 fusion Knock-in ; Hes5/Eluc KI|
|H-2 Haplotype||No Data|
|ES cell line||TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1]|
|Background strain||No Data|
|Strain development||Developed by Itaru Imayoshi and Ryoichiro Kageyama, Institute for Virus Research, Kyoto University in 2010. TT2 ES cells were used. The mutant mice were crossed to ICR.|
|Strain description||Eluc/Hes5 knock-in mice. Eluc-Hes5 fusion protein is expressed from Hes5 locus.|
|Colony maintenance||Heterozygote x Wild-type [or Crossing to Slc:ICR]|
BRC facility Health Report in the last year and a half
|Symbol name||hairy and enhancer of split 5 (Drosophila)|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||No Data|
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Science DOI: 10.1126/science.1242366
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. The RECIPIENT of BIOLOGICAL resource shall obtain a prior written consent on use of it from the DEPOSITOR Dr. Itaru Imayoshi (E-mail: email@example.com) and Ryoichiro Kageyama (E-mail: firstname.lastname@example.org ). (No approval form (Form D) is necessary).
|2||Genotyping protocol <PCR>|
|Depositor||Imayoshi, Itaru (Institute for Virus Research, Kyoto University)|
|Strain Status /